Medidata Reports Record Second Quarter 2016 Results

Go back to Medidata Reports Record Second Quarter 2016 Results

Needham & Company Reiterates Buy on Medidata Solutions (MDSO) Following Strong 2Q Results

July 21, 2016 8:32 AM EDT

Needham & Company reiterated a Buy rating on Medidata Solutions (NASDAQ: MDSO), and raised the price target to $60.00 (from $55.00), following the company's 2Q earnings report. MDSO reported revenues of $114.6mm, ahead of $112.4mm estimate. EPS of $0.24 also beat estimates with a $0.23 consensus.

Analyst Scott Berg... More

Wells Fargo Downgrades Medidata Solutions (MDSO) to Market Perform

July 21, 2016 6:48 AM EDT

Wells Fargo downgraded Medidata Solutions (NASDAQ: MDSO) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.

Shares of Medidata Solutions closed at $53.58 yesterday.

... More

Medidata Solutions (MDSO) Tops Q2 EPS by 1c; Reiterates Outlook

July 20, 2016 6:31 AM EDT

Medidata Solutions (NASDAQ: MDSO) reported Q2 EPS of $0.24, $0.01 better than the analyst estimate of $0.23. Revenue for the quarter came in at $114.6 million versus the consensus estimate of $112.39 million.

Our second quarter results come from strong execution across the Company and reflect Medidatas momentum in driving adoption of our integrated cloud platform, said Tarek Sherif, Medidatas chairman and chief executive officer. With demand growing for Medidata CTMS, Payments, Balance and mHealth, as well as... More